Even with the limited number of antirheumatic agents available, theoretical
considerations lead to an almost infinite number of combination strategies
. This article outlines possible strategies based on the primary choice bet
ween maximization of efficacy or minimization of toxicity. Strategies are i
llustrated with examples from trial experience in the field of rheumatoid a
rthritis.